8:07AM Sinovac Biotech receives Beijing CDC tender award to supply seasonal flu vaccine Anflu to Beijing Citizens (SVA) 2.16 : The Beijing CDC plans to order up to a total of 1.8 million doses of seasonal flu vaccine in 2012 for the vaccination campaign from four vaccine manufacturers. The total quantity of vaccine doses to be supplied will depend on the actual demand in Beijing. Delivery is expected to commence during the third quarter of 2012. In 2011, total about 360,000 doses of Anflu were inoculated to the target population for the vaccination campaign in Beijing. According to public data as of November 22, 2011, over 1.3 million doses of seasonal flu vaccines were inoculated in Beijing, inclusive of the target population covered by the free vaccination campaign.
Recent SVA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2026 09:21:42 PM
- SINOVAC Reports Unaudited First Half of 2025 Financial Results • Business Wire • 05/08/2026 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/07/2026 11:05:04 AM
- SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 • Business Wire • 04/30/2026 01:22:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 10:10:11 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:34:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:29:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:28:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:10:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:06:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:24:16 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/30/2026 08:24:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:24:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:47 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/30/2026 08:23:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:19 PM
- SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing • Business Wire • 01/22/2026 11:00:00 AM
- SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement • Business Wire • 01/04/2026 03:13:00 PM
- Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report • Business Wire • 01/04/2026 03:00:00 PM
- 安提瓜法院作出临时裁决:授予董事会在2025 年股东会议争议案庭审前对公司的控制权 • Business Wire • 12/17/2025 12:01:00 PM
- Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting • Business Wire • 12/17/2025 12:00:00 PM
- /C O R R E C T I O N -- Heng Ren Partners/ • PR Newswire (US) • 11/12/2025 03:32:00 AM
- /C O R R E C T I O N -- Heng Ren Partners/ • PR Newswire (US) • 11/11/2025 11:40:00 PM

